BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9554269)

  • 1. Oral delivery of micro-encapsulated DNA vaccines.
    Jones DH; Clegg JC; Farrar GH
    Dev Biol Stand; 1998; 92():149-55. PubMed ID: 9554269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.
    Jones DH; Corris S; McDonald S; Clegg JC; Farrar GH
    Vaccine; 1997 Jun; 15(8):814-7. PubMed ID: 9234522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
    Jones DH; Partidos CD; Steward MW; Farrar GH
    Behring Inst Mitt; 1997 Feb; (98):220-8. PubMed ID: 9382743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid protein.
    Fooks AR; Sharpe SA; Shallcross JA; Clegg JC; Cranage MP
    Dev Biol (Basel); 2000; 104():65-71. PubMed ID: 11713826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
    Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.
    Stanley AC; Buxton D; Innes EA; Huntley JF
    Vaccine; 2004 Sep; 22(29-30):3929-41. PubMed ID: 15364441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductive pathways leading to rat tear IgA antibody responses.
    Ridley Lathers DM; Gill RF; Montgomery PC
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1005-11. PubMed ID: 9579480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
    Challacombe SJ; Rahman D; Jeffery H; Davis SS; O'Hagan DT
    Immunology; 1992 May; 76(1):164-8. PubMed ID: 1628895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.
    He XW; Wang F; Jiang L; Li J; Liu SK; Xiao ZY; Jin XQ; Zhang YN; He Y; Li K; Guo YJ; Sun SH
    J Gen Virol; 2005 Mar; 86(Pt 3):601-610. PubMed ID: 15722520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.
    Manocha M; Pal PC; Chitralekha KT; Thomas BE; Tripathi V; Gupta SD; Paranjape R; Kulkarni S; Rao DN
    Vaccine; 2005 Dec; 23(48-49):5599-617. PubMed ID: 16099080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The formulation and immunisation of oral poly(DL-lactide-co-glycolide) microcapsules containing a plasmid vaccine against lymphocystis disease virus in Japanese flounder (Paralichthys olivaceus).
    Tian J; Sun X; Chen X; Yu J; Qu L; Wang L
    Int Immunopharmacol; 2008 Jun; 8(6):900-8. PubMed ID: 18442796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
    Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
    J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
    Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
    Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
    Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
    Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice.
    Cai H; Hu XD; Yu DH; Li SX; Tian X; Zhu YX
    Vaccine; 2005 Jul; 23(32):4167-74. PubMed ID: 15908060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
    Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of the design and delivery of microparticles for vaccine applications.
    Jenkins PG; Coombes AG; Yeh MK; Thomas NW; Davis SS
    J Drug Target; 1995; 3(1):79-81. PubMed ID: 7655826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.